Thoracic Surgery (Cardiothoracic Vascular Surgery)
Audio Summaries

Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children: The IRMA Randomized Clinical Trial

The study aimed to determine whether universal iron interventions combined with malaria chemoprevention would enhance cognitive outcomes and safety regarding infection risk in rural Malawian children. The results indicated that neither iron syrup nor iron-containing micronutrient powders improved cognitive scores compared to malaria chemoprevention alone, and both iron interventions did not increase malaria risk. Overall, the findings suggest that these iron interventions did not provide the expected functional benefits in this population.

Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association

This scientific statement from the American Heart Association addresses the urgent need to improve outcomes in pediatric cardiogenic shock, a condition associated with high morbidity and mortality. The authors aim to establish a diagnostic framework and severity staging for clinicians, while also proposing strategies for timely diagnosis, management, and monitoring of affected children. Additionally, they highlight future research directions, including the development of clinical decision tools and the role of multidisciplinary teams in enhancing care for these patients.

[¹⁷⁷Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

The PSMAddition trial aimed to evaluate the efficacy and safety of combining [^177Lu]Lu-PSMA-617 with androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI) in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer. The results indicated that this combination significantly improved radiographic progression-free survival compared to the control group, despite a higher incidence of adverse events, suggesting it may be a viable new treatment option for this patient population.

Syncope

This article by Rose Anne Kenny addresses the clinical problem of syncope, which is characterized by transient cerebral hypoperfusion and can arise from various mechanisms such as reflex, orthostatic, and cardiac causes. The authors emphasize the importance of accurate diagnosis through thorough history taking, physical examination, and risk stratification to guide targeted testing and management strategies aimed at reducing recurrence and injury risk, particularly in older patients where syncope may present as unexplained falls. The study highlights the necessity of early identification of high-risk features to prevent adverse cardiovascular outcomes.

Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial

The ICECAP randomized clinical trial aimed to determine the optimal duration of therapeutic hypothermia at 33 °C for maximizing neurological recovery in comatose survivors of out-of-hospital cardiac arrest. The study found that increasing the duration of cooling did not improve neurological outcomes, with a posterior probability suggesting that a 6-hour duration may be optimal. Overall, no significant differences in secondary outcomes or mortality were observed across varying cooling durations.

COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34⁺ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis

The authors investigate the mechanisms behind the accumulation of CD34⁺ foam-like macrophages in chronic transplant arteriosclerosis, a major cause of graft failure. They identify a novel proinflammatory macrophage phenotype driven by COL1A1-enhanced cystine uptake, which activates mTORC1-HIF-1α signaling and promotes lipogenesis. The findings suggest potential therapeutic targets to modulate the immune response and improve transplant outcomes.

Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury

The authors investigate the role of LAPTM4A, a lysosome-localized protein, in protecting against myocardial ischemia-reperfusion (MIR) injury, a condition that complicates heart revascularization. Their findings reveal that LAPTM4A enhances autophagic flux by interacting with Rubicon, thereby reducing inflammation and cell death during reperfusion. This suggests that targeting LAPTM4A could be a novel therapeutic strategy to mitigate MIR injury.

Loss of the Coronary Artery Disease Risk Gene <em>LMOD1</em> in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis

The authors investigate the role of the coronary artery disease risk gene LMOD1 in vascular smooth muscle cells (VSMCs) and its impact on coronary atherosclerosis. They find that loss of LMOD1 in VSMCs leads to rapid-onset coronary atherosclerosis under atherogenic conditions, highlighting LMOD1's protective role in maintaining coronary artery homeostasis. The study suggests that LMOD1 functions independently of actin nucleation to prevent the development of atherosclerosis.

Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis

The authors aimed to characterize the incidence and predictors of extracranial bleeding in patients with atrial fibrillation (AF) receiving oral anticoagulants (OACs) and to quantify the population attributable fraction of identified risk factors. They found that 26% of patients experienced clinically relevant extracranial bleeding, with gastrointestinal bleeds being the most common site, and identified consistent risk factors across bleeding severity categories. Their models explained approximately two-thirds of the population attributable risk, indicating that additional factors may also influence bleeding risk.

Ten Years of Scientific Discovery With the UK Biobank Cardiovascular Magnetic Resonance Imaging Study

This article reviews the impact of the UK Biobank Cardiovascular Magnetic Resonance Imaging Study, which has facilitated significant advancements in cardiovascular research by linking high-quality imaging data from 100,000 participants with extensive genetic and clinical information. The authors aim to highlight the study's contributions to genomics, epidemiology, and biomedical engineering, while also discussing its limitations and future directions for enhancing cardiovascular health through collaborative science. They emphasize the importance of methodological rigor and harmonization in future imaging cohort studies.